[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:cardiogenic-shock":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":129,"states":130},"Cardiogenic Shock",19,15,[8,15,21,28,35,42,48,54,60,66,72,78,84,90,96,102,109,115,122],{"nct_id":9,"title":10,"phases":11,"status":12,"updated_at":13,"content_modified":14},"NCT05485376","Pulmonary Artery Catheter in Cardiogenic Shock Trial",[],"RECRUITING","2026-08-26T02:18:57.189473Z","2026-05-05T02:43:29.395389Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":19,"content_modified":20},"NCT04419480","Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial",[],"2026-08-26T02:18:23.582895Z","2026-05-05T02:43:29.381626Z",{"nct_id":22,"title":23,"phases":24,"status":12,"updated_at":26,"content_modified":27},"NCT05267886","CAPITAL DOREMI 2: Inotrope Versus Placebo Therapy for Cardiogenic Shock",[25],"Phase 4","2026-08-26T02:18:08.005333Z","2026-05-05T02:43:28.527730Z",{"nct_id":29,"title":30,"phases":31,"status":12,"updated_at":33,"content_modified":34},"NCT05700617","Cardiac Power Output in Cardiogenic Shock Patients",[32],"Early Phase 1","2026-08-26T02:18:12.612955Z","2026-05-05T02:43:28.173857Z",{"nct_id":36,"title":37,"phases":38,"status":12,"updated_at":40,"content_modified":41},"NCT06336655","Physiology of Unloading VA ECMO Trial",[39],"Phase 2","2026-08-26T02:16:46.147215Z","2026-05-05T02:43:27.504643Z",{"nct_id":43,"title":44,"phases":45,"status":12,"updated_at":46,"content_modified":47},"NCT05298124","Transcatheter Mitral Valve Repair for Inotrope Dependent Cardiogenic Shock",[],"2026-08-26T02:18:46.137046Z","2026-05-05T02:43:27.311322Z",{"nct_id":49,"title":50,"phases":51,"status":12,"updated_at":52,"content_modified":53},"NCT06080074","Multicenter Trial of ECMO in Children With Severe Cardiac Failure Using the Cardiohelp System",[39],"2026-08-26T02:19:18.331180Z","2026-05-05T02:43:28.316471Z",{"nct_id":55,"title":56,"phases":57,"status":12,"updated_at":58,"content_modified":59},"NCT07656259","COMPARE-VENT Feasibility Pilot Study",[],"2026-08-26T02:17:13.277148Z","2026-06-18T12:24:03.101473Z",{"nct_id":61,"title":62,"phases":63,"status":12,"updated_at":64,"content_modified":65},"NCT06964685","Assessment of Support With Impella® Best Practices in Acute Myocardial Infarction Complicated by Cardiogenic Shock",[],"2026-08-26T02:17:03.534765Z","2026-07-05T05:32:16.721596Z",{"nct_id":67,"title":68,"phases":69,"status":12,"updated_at":70,"content_modified":71},"NCT07402018","Intra-aortic Balloon Counterpulsation (IABC) Compliance",[],"2026-08-26T02:15:38.131683Z","2026-05-13T02:55:06.699751Z",{"nct_id":73,"title":74,"phases":75,"status":12,"updated_at":76,"content_modified":77},"NCT06253104","Changes in Skeletal Muscle Thickness in Patients With Acute Heart Failure",[],"2026-08-26T02:16:38.053590Z","2026-05-13T02:55:06.428605Z",{"nct_id":79,"title":80,"phases":81,"status":12,"updated_at":82,"content_modified":83},"NCT05426083","Left Ventricular Physiological Effects of Veno-Arterial Extracorporeal Membrane Oxygenation Support During Cardiogenic Shock",[],"2026-08-03T03:46:02.954252Z","2026-05-13T02:55:06.348183Z",{"nct_id":85,"title":86,"phases":87,"status":12,"updated_at":88,"content_modified":89},"NCT05185492","Multi-center Collaborative to Enhance Quality and Outcomes in the Management of Cardiogenic Shock",[],"2026-08-26T02:17:55.355429Z","2026-05-13T02:55:06.294567Z",{"nct_id":91,"title":92,"phases":93,"status":12,"updated_at":94,"content_modified":95},"NCT04682483","Cardiogenic Shock Working Group Registry",[],"2026-08-26T02:19:15.498463Z","2026-05-13T02:55:06.258585Z",{"nct_id":97,"title":98,"phases":99,"status":12,"updated_at":100,"content_modified":101},"NCT03378739","Inova Cardiogenic Shock Registry (INOVA SHOCK)",[],"2026-08-26T02:19:22.562392Z","2026-05-13T02:55:06.122473Z",{"nct_id":103,"title":104,"phases":105,"status":106,"updated_at":107,"content_modified":108},"NCT07461961","CORTISHOCK-P: Trial of Corticosteroids in Inflammation-Enriched Heart Failure Cardiogenic Shock",[39],"NOT_YET_RECRUITING","2026-08-26T02:19:19.162260Z","2026-05-05T02:43:28.126871Z",{"nct_id":110,"title":111,"phases":112,"status":106,"updated_at":113,"content_modified":114},"NCT06965504","INitiation and Titration of Guideline Directed Medical TheRApy in HearT Failure Cardiogenic Shock With ImpElla 5.5 for Cardiac Recovery",[],"2026-08-26T02:18:42.501841Z","2026-05-05T02:43:27.447881Z",{"nct_id":116,"title":117,"phases":118,"status":119,"updated_at":120,"content_modified":121},"NCT07141524","Optimizing Breathing and Blood Flow in Patients Treated With VA ECMO",[],"ENROLLING_BY_INVITATION","2026-08-26T02:16:01.910993Z","2026-06-16T05:54:07.857191Z",{"nct_id":123,"title":124,"phases":125,"status":126,"updated_at":127,"content_modified":128},"NCT06713668","Augmented Pacing for Shock in the Cardiac Intensive Care Unit",[],"ACTIVE_NOT_RECRUITING","2026-08-03T02:36:24.364783Z","2026-05-05T02:43:27.505468Z",[],[131,135,139,142,146,150,153,156],{"state":132,"count":133,"slug":134},"Massachusetts",6,"massachusetts",{"state":136,"count":137,"slug":138},"Minnesota",5,"minnesota",{"state":140,"count":137,"slug":141},"Virginia","virginia",{"state":143,"count":144,"slug":145},"Florida",4,"florida",{"state":147,"count":148,"slug":149},"Illinois",3,"illinois",{"state":151,"count":148,"slug":152},"Pennsylvania","pennsylvania",{"state":154,"count":148,"slug":155},"Tennessee","tennessee",{"state":157,"count":148,"slug":158},"Texas","texas"]